CCR6 and cancer: The recruitment of TH17 cells expressing their signature chemokine, CCR6, is said to be polyfunctional within the tumor microenvironment, because these vells possess stem-like properties and mediate anti-tumor activity via the engagement of CD8+ T cells, NK cells, and DCs to sites of inflammation and cancer.